Genetic alterations disrupting the nuclear localization of the retinoblastoma-related gene RB2/p130 in human tumor cell lines and primary tumors - PubMed (original) (raw)

. 2000 Jan 15;60(2):383-9.

Affiliations

• PMID: 10667591

Genetic alterations disrupting the nuclear localization of the retinoblastoma-related gene RB2/p130 in human tumor cell lines and primary tumors

C Cinti et al. Cancer Res. 2000.

Abstract

The prototypic tumor suppressor gene, the retinoblastoma gene (RB/ p105), is mutated in a variety of human tumors. However, to date, mutational data on retinoblastoma family members p107 and RB2/p130 in tumors is lacking. We studied the expression of pRb2/p130 by immunocytochemistry and Western blot analysis in a panel of human osteosarcoma and lymphoid cell lines. Only the lymphoid cell lines showed an abnormal cytoplasmic localization of pRb2/p130, suggesting possible alterations within the region of nuclear localization signaling. We screened these cell lines for genetic alterations of the RB2/p130 gene in the region of the putative bipartite nuclear localization signal (NLS). This region is highly homologous with that of the RB/p105 gene. In addition, we screened four primary Burkitt's lymphomas for genetic alterations in the RB2/p130 gene. Naturally occurring mutations, which disrupt the putative bipartite NLS, were found in lymphoma cell lines and primary tumors, but not in the osteosarcoma cell lines, where normal nuclear localization of the protein was detectable. Site-directed mutagenesis and transfection assay using NLS mutants displayed markedly reduced biological activity as measured by flow cytometric analysis. This study clearly describes RB2/ p130 as an important target for mutations and subsequent inactivation in lymphoma pathogenesis, thus validating that RB2/p130 is a classical tumor suppressor gene.

PubMed Disclaimer

Similar articles

• Mutations in the retinoblastoma-related gene RB2/p130 in lung tumors and suppression of tumor growth in vivo by retrovirus-mediated gene transfer.
  Claudio PP, Howard CM, Pacilio C, Cinti C, Romano G, Minimo C, Maraldi NM, Minna JD, Gelbert L, Leoncini L, Tosi GM, Hicheli P, Caputi M, Giordano GG, Giordano A. Claudio PP, et al. Cancer Res. 2000 Jan 15;60(2):372-82. Cancer Res. 2000. PMID: 10667590
• Retinoblastoma-related geneRb2/p130 are rarely mutated in Burkitt's lymphoma from Brazil.
  Klumb CE, Magluta EP, Rezende LM, Apa AG, Alonso JF, Maia RC. Klumb CE, et al. Am J Hematol. 2007 Mar;82(3):238-9. doi: 10.1002/ajh.20749. Am J Hematol. 2007. PMID: 16955460
• Reduced transcription of the RB2/p130 gene in human lung cancer.
  Xue Jun H, Gemma A, Hosoya Y, Matsuda K, Nara M, Hosomi Y, Okano T, Kurimoto F, Seike M, Takenaka K, Yoshimura A, Toyota M, Kudoh S. Xue Jun H, et al. Mol Carcinog. 2003 Nov;38(3):124-9. doi: 10.1002/mc.10152. Mol Carcinog. 2003. PMID: 14587097
• Who is the boss in the retinoblastoma family? The point of view of Rb2/p130, the little brother.
  Paggi MG, Giordano A. Paggi MG, et al. Cancer Res. 2001 Jun 15;61(12):4651-4. Cancer Res. 2001. PMID: 11406530 Review.
• Rb2/p130 and protein phosphatase 2A: key mediators of ovarian carcinoma cell growth suppression by all-trans retinoic acid.
  Soprano KJ, Purev E, Vuocolo S, Soprano DR. Soprano KJ, et al. Oncogene. 2006 Aug 28;25(38):5315-25. doi: 10.1038/sj.onc.1209679. Oncogene. 2006. PMID: 16936753 Review.

Cited by

• Medulloblastoma: from molecular pathology to therapy.
  Rossi A, Caracciolo V, Russo G, Reiss K, Giordano A. Rossi A, et al. Clin Cancer Res. 2008 Feb 15;14(4):971-6. doi: 10.1158/1078-0432.CCR-07-2072. Clin Cancer Res. 2008. PMID: 18281528 Free PMC article. Review.
• pRb2/p130 protein in relation to clinicopathological and biological variables in rectal cancers with a clinical trial of preoperative radiotherapy.
  Moparthi SB, Bergman V, Adell G, Thorstensson S, Sun XF. Moparthi SB, et al. Int J Colorectal Dis. 2009 Nov;24(11):1303-10. doi: 10.1007/s00384-009-0767-2. Epub 2009 Jul 14. Int J Colorectal Dis. 2009. PMID: 19597825 Clinical Trial.
• Mutation screening analysis of the retinoblastoma related gene RB2/p130 in sporadic ovarian cancer and head and neck squamous cell cancer.
  Alvi AJ, Hogg R, Rader JS, Kuo MJ, Maher ER, Latif F. Alvi AJ, et al. Mol Pathol. 2002 Jun;55(3):153-5. doi: 10.1136/mp.55.3.153. Mol Pathol. 2002. PMID: 12032225 Free PMC article.
• Burkitt's lymphoma: new insights into molecular pathogenesis.
  Bellan C, Lazzi S, De Falco G, Nyongo A, Giordano A, Leoncini L. Bellan C, et al. J Clin Pathol. 2003 Mar;56(3):188-92. doi: 10.1136/jcp.56.3.188. J Clin Pathol. 2003. PMID: 12610094 Free PMC article. Review.
• Mechanisms involved in Burkitt's tumor formation.
  Campanero MR. Campanero MR. Clin Transl Oncol. 2008 May;10(5):250-5. doi: 10.1007/s12094-008-0193-x. Clin Transl Oncol. 2008. PMID: 18490240 Review.

Publication types

MeSH terms

Substances